机器人与腹腔镜胃癌根治术长期疗效比较:2084例倾向评分加权分析
该研究基于2009至2017年2084例Ⅰ–Ⅲ期胃癌患者,采用广义提升法倾向评分加权比较机器人与腹腔镜胃切除术的长期结局。中位随访52个月,两组5年总生存与无复发生存均无显著差异,机器人组失血量少16 mL。
要点
- 机器人胃癌根治术与腹腔镜手术的5年总生存和无复发生存相似。
- 机器人组术中失血量较腹腔镜组少16 mL(P=0.025)。
- 机器人手术自初始阶段即可获得足够淋巴结清扫,且手术结局随时间稳定。
核心结论
- 倾向评分加权平衡协变量后,机器人胃癌根治术自初始阶段即显示可靠的手术结局。
- 机器人与腹腔镜胃癌根治术后的长期生存相似。
研究设计与样本
- 研究纳入2009至2017年间接受腹腔镜或机器人胃癌根治术的Ⅰ–Ⅲ期胃癌患者共2084例。
- 采用广义提升法基于所有可用术前特征估计倾向评分,并以调整Kaplan-Meier法和加权Cox比例风险回归模型比较长期结局。
主要发现
- 倾向评分加权后人群基线均衡。
- 机器人组失血量较腹腔镜组少16 mL(P=0.025),初始阶段淋巴结清扫充分,手术结局随时间无变化。
- 中位随访52个月,未加权人群5年总生存:腹腔镜组91.5% vs 机器人组94%(HR 0.71,95%CI 0.46-1.1,P=0.126)。
- 加权人群5年总生存:腹腔镜组94.2% vs 机器人组93.2%(HR 0.88,95%CI 0.52-1.48,P=0.636)。
- 未加权5年无复发生存:腹腔镜组95.4% vs 机器人组95.2%(HR 0.95,95%CI 0.55-1.64,P=0.845);加权5年无复发生存:腹腔镜组96.3% vs 机器人组95.3%(HR 1.24,95%CI 0.66-2.33,P=0.498)。
临床怎么用
- 机器人胃癌根治术可作为腹腔镜手术的可行替代方案,长期肿瘤学结局相似。
- 机器人手术在减少术中失血方面可能具有优势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare long-term outcomes between robotic and LG approaches using propensity score weighting based on a generalized boosted method to control for selection bias. SUMMARY OF BACKGROUND DATA: Minimally invasive surgical approaches for GC are increasing, yet limited evidence exists for long-term outcomes of robotic gastrectomy (RG). METHODS: Patients (n = 2084) with GC stages I-III who underwent LG or RG between 2009 and 2017 were analyzed. Generalized boosted method was used to estimate a propensity score derived from all available preoperative characteristics. Long-term outcomes were compared using the adjusted Kaplan-Meier method and the weighted Cox proportional hazards regression model. RESULTS: After propensity score weighting, the population was balanced. Patients who underwent RG showed reduced blood loss (16 mL less, P = 0.025), sufficient lymph node harvest from the initial period, and no changes in surgical outcomes over time. With 52-month median follow-up, no difference was noted in 5-year overall survival in unweighted [91.5% in LG vs 94% in RG; hazard ratio (HR), 0.71; 95% confidence interval (CI), 0.46-1.1; P = 0.126] and weighted populations (94.2% in LG vs 93.2% in RG; HR, 0.88; 95% CI, 0.52-1.48; P = 0.636). There were no differences in 5-year recurrence-free survival (RFS), with unweighted 5-year RFS of 95.4% for LG and 95.2% for RG (HR, 0.95; 95% CI, 0.55-1.64; P = 0.845) and weighted 5-year RFS of 96.3% for LG and 95.3% for RG (HR, 1.24; 95% CI, 0.66-2.33; P = 0.498). CONCLUSIONS: After balancing covariates, RG demonstrated reliable surgical outcomes from the beginning. Long-term survival after RG and LG for GC was similar.
引用
- Shin HJ, Son SY, Wang B, et al. Long-term Comparison of Robotic and Laparoscopic Gastrectomy for Gastric Cancer: A Propensity Score-weighted Analysis of 2084 Consecutive Patients. Ann Surg. 2021. PMID: 32187032. doi:10.1097/SLA.0000000000003845
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。